Microarray analysis of gene expression in murine skin exposed to sulfur mustard

Journal of Biochemical and Molecular Toxicology

Volumn 18, Issue 6, 2005, Pages 289-299

  Rogers, James V ^a   Choi, Young W ^a   Kiser, Robyn C ^a   Babin, Michael C ^a   Casillas, Robert P ^a   Schlager, John J ^b,c   Sabourin, Carol L K ^a  

^a BATTELLE MEMORIAL INSTITUTE   (United States)

^b US ARMY MEDICAL RESEARCH INSTITUTE OF CHEMICAL DEFENSE   (United States)

^c AIR FORCE RESEARCH LABORATORY   (United States)

Author keywords

Gene Expression; Inflammation; Microarray; Mouse; Skin; Sulfur Mustard (SM)

Indexed keywords

DICHLOROMETHANE; MUSTARD GAS; TRANSCRIPTION FACTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL CYCLE; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; DRUG EXPOSURE; EAR; GENE EXPRESSION; GENETIC SELECTION; INFLAMMATION; MALE; MOUSE; NONHUMAN; ONCOGENE; SKIN; TUMOR SUPPRESSOR GENE; UPREGULATION;

MURINAE;

EID: 12844249968     PISSN: 10956670     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbt.20043     Document Type: Article

References (65)

1. Sidell FR, Urbanetti JS, Smith WJ, Hurst CG. Vesicants. In: Sidell FR, Takafuji ET, Franz DR, editors. Textbook of military medicine, warfare, weaponry, and the casualty. Medical aspects of chemical and biological warfare. Washington, DC: TMM Publications; 1997. p 197-228.
2. Papirmeister B, Gross CL, Petrali JP, Hixson CJ. Pathology produced by sulfur mustard in human skin grafts on athymic nude mice I. Gross and light microscopic changes. J Toxicol Cutan Ocular Toxicol 1984;3:371-408.
3. Mitcheltree LW, Mershon MM, Wall HG, Pulliam JD. Microblister formation in vesicant-exposed pig skin. J Toxicol Cutan Ocular Toxicol 1989;8:309-319.
4. Petrali JP, Oglesby SB, Mills KR. Ultrastructural correlates of sulfur mustard toxicity. J Toxicol Cutan Ocular Toxicol 1990;9:193-214.
5. Smith KJ, Skelton HG, Hobson DW, Reid FM, Blank JA, Hurst CG. Cutaneous histopathologic features in weanling pigs after exposure to three different doses of liquid sulfur mustard. Am J Dermatopathol 1996;18:515-520.
6. Smith KJ, Casillas R, Graham J, Skelton HG, Stemler F, Hackley BE Jr. Histopathogic features seen with different animal models following cutaneous sulfur mustard exposure. J Dermatol Sci 1997;14:126-135.
7. Casillas RP, Mitcheltree LW, Stemler FW. The mouse ear model of cutaneous sulfur mustard injury. Toxicol Methods 1997,7:381-397.
8. Casillas RP, Kiser RC, Truxall JA, Singer AW, Shumaker SM, Niemuth NA, Ricketts KM, Mitcheltree LW, Castrejon LR, Blank JA. Therapeutic approaches to dermatotoxicity by sulfur mustard I. Modulation of sulfur mustard-induced cutaneous injury in the mouse ear vesicant model. J Appl Toxicol 2000;20:S145-S151.
9. Sabourin CLK, Danne MM, Buxton KL, Rogers JV, Niemuth NA, Blank JA, Babin MC, Casillas RP. Modulation of sulfur mustard-induced inflammation and gene expression by olvanil in the hairless mouse vesicant model. J Toxicol Cutan Ocular Toxicol 2003;22:125-136.
10. Bowcock AM, Shannon W, Du F, Duncan J, Cao K, Aftergut K, Catier J, Fernandez-Vina MA, Menter A. Insights into psoriasis and other inflammatory diseases from large-scale gene expression studies. Hum Mol Genet 2001;10:1793-1805.
11. Cole J, Tsou R, Wallace K, Gibran N, Isik F. Comparison of normal human skin gene expression using cDNA microarrays. Wound Repair Regen 2001;9:77-85.
12. Curto EV, Lambert GW, Davis RL, Wilborn TW, Dooley TP. Biomarkers of human skin cells identified using DermArray DNA arrays and new bioinformatics methods. Biochem Biophys Res Commun 2002;291:1052-1064.
13. Oestreicher JL, Walters IB, Kikuchi T, Gilleaudeau P, Surette J, Schwertschlag U, Dorner AJ, Krueger JG, Trepicchio WL. Molecular classification of psoriasis disease-associated genes through pharmacogenomic expression profiling. Pharmacogenomics J 2001;1:272-287.
14. Sesto A, Navarro M, Burslem F, Jorcano JL. Analysis of the ultraviolet B response in primary human keratinocytes using oligonucleotide microarrays. Proc Natl Acad Sci USA 2002;99:2965-2970.
15. Takao J, Ariizumi K, Dougherty II, Cruz PD Jr. Genomic scale analysis of the human keratinocyte response to broad-band ultraviolet-B irradiation. Photodermatol Photoimmunol Photomed 2002;18:5-13.
16. Wang Z, Liu Y, Mori M, Kulesz-Martin M. Gene expression profiling of initiated epidermal cells with benign or malignant tumor fates. Carcinogenesis 2002;23:635-643.
17. Rogers JV, Garrett CM, McDougal JN. Gene expression in rat skin induced by irritating chemicals. J Biochem Mol Toxicol 2003;17:123-137.
18. Sabourin CLK, Petrali JP, Casillas RP. Inflammatory gene expression in sulfur mustard exposed mouse skin. J Biochem Mol Toxicol 2000;14:291-302.
19. Sabourin CLK, Danne MM, Buxton KL, Casillas RP, Schlager JJ. Cytokine, chemokine, and matrix metalloproteinase response after sulfur mustard injury to weanling pig skin. J Biochem Mol Toxicol 2002;16:263-272.
20. Yourick JJ, Dawson JS, Mitcheltree LW. Reduction of erythema in hairless guinea pigs after cutaneous sulfur mustard vapor exposure by pretreatment with niacinamide, promethazine and indomethacin. J Appl Toxicol 1995;15:133-138.
21. Wormser U, Brodsky B, Green BS, Arad-Yellin R, Nyska A. Protective effect of povidone-iodine ointment against skin lesions induced by sulphur and nitrogen mustards and by non-mustard vesicants. Arch Toxicol 1997;71:165-170.
22. Babin MC, Ricketts K, Skvorak JP, Gazaway M, Mitcheltree LW, Casillas RP. Systemic administration of candidate antivesicants to protect against topically applied sulfur mustard in the mouse ear vesicant model (MEVM). J Appl Toxicol 2000;20:S141-S144.
23. Cowan FM, Broom Fi Eld CA, Lenz DE, Smith WJ. Putative role of proteolysis and inflammatory response in the toxicity of nerve and blister chemical warfare agents: Implications for multi-threat medical countermeasures. J Appl Toxicol 2003;23:177-186.
24. Dabrowska MI, Becks LL, Lelli JL Jr, Levee MG, Hinshaw DB. Sulfur mustard induces apoptosis and necrosis in endothelial cells. Toxicol Appl Pharmacol 1996;141:568-583.
25. 2+-calmodulin and caspase-dependent pathway. J Invest Dermatol 1998;111:64-71.
26. Ricketts KM, Santai CT, France JA, Graziosi AM, Doyel TD, Gazaway MY, Casillas RP. Inflammatory cytokine responses in sulfur mustard exposed mouse skin. J Appl Toxicol 2000;20:S73-S76.
27. Rosenthal DS, Simbulan-Rosenthal CM, Iyer S, Smith WJ, Ray R, Smulson ME. Calmodulin, poly(ADP-ribose)polymerase and p53 are targets for modulating the effects of sulfur mustard. J Appl Toxicol 2000;20:S43-S49.
28. Sehgal PB. Interleukin-6: Molecular pathophysiology. J Invest Dermatol 1990;94:2S-6S.
29. Caughman SW, Li LJ, Degitz K. Human intercellular adhesion molecule-1 gene and its expression in the skin. J Invest Dermatol 1992;98:61S-65S.
30. Swerlick RA, Lawley TJ. Role of microvascular endothelial cells in inflammation. J Invest Dermatol 1993;100:111S-115S.
31. Santamaria Babi LF, Perez Soler MT, Hauser C, Blaser K. Skin-homing T cells in human cutaneous allergic inflammation. Immunol Res 1995;14:317-324.
32. Paquet P, Pierard GE. Interleukin-6 and the skin. Int Arch Allergy Immunol 1996;109:308-317.
33. Corsini E, Galli CL. Cytokines and irritant contact dermatitis. Toxicol Lett 1998;102-103:277-282.
34. Gallo RL. Proteoglycans and cutaneous vascular defense and repair. J Invest Dermatol Symp Proc 2000;5:55-60.
35. Donnerer J, Schuligoi R, Stein C. Increased content and transport of substance P and calcitonin gene-related peptide in sensory nerves innervating inflamed tissue: Evidence for a regulatory function of nerve growth factor in vivo. Neuroscience 1992;49:693-698.
36. Bonini S, Lambiase A, Bonini S, Angelucci F, Magrini L, Manni L, Aloe L. Circulating nerve growth factor levels are increased in humans with allergic diseases and asthma. Proc Natl Acad Sci USA 1996;93:10955-10960.
37. Aloe L, Bracci-Laudiero L, Bonini S, Manni L. The expanding role of nerve growth factor: From neurotrophic activity to immunologic diseases. Allergy 1997;52:883-894.
38. Foster PA, Wicks S, Foster M, Brain SD. Cellular pathology changes in rat skin following intradermal injection of nerve growth factor: Neutrophil-dependent and -independent events. J Pathol 2002;245-255.
39. Toyoda M, Nakamura M, Makino T, Hino T, Kagoura M, Morohashi M. Nerve growth factor and substance P are useful plasma markers of disease activity in atopic dermatitis. Br J Dermatol 2002;147:71-79.
40. Cao T, Pintér E, Al-Rashed S, Gerard N, Hoult JR, Brain SD. Neurokinin-1 receptor agonists are involved in mediating neutrophil accumulation in the inflamed, but not normal, cutaneous microvasculature: An in vivo study using neurokinin-1 receptor knockout mice. J Immunol 2000;164:5424-5429.
41. Matis WL, Lavker RM, Murphy GF. Substance P induces the expression of an endothelial-leukocyte adhesion molecule by microvascular endothelium. J Invest Dermatol 1990;94:492-495.
42. Smith CH, Barker JN, Morris RW, MacDonald DM, Lee TH. Neuropeptides induce rapid expression of endothelial cell adhesion molecules and elicit granulocytic infiltration in human skin. J Immunol 1993;151:3274-3282.
43. Viac J, Guéniche A, Doutremepuich JD, Reichert U, Claudy A, Schmitt D. Substance P and keratinocyte activation markers: An in vitro approach. Arch Dermatol Res 1996;288:85-90.
44. Quinlan KL, Naik SM, Cannon G, Armstrong CA, Bunnett NA, Ansel JC, Caughman SW. Substance P activates coincident NF-AT- and NF-κB-dependent adhesion molecule gene expression in microvascular endothelial cells through intracellular calcium mobilization. J Immunol 1999;163:5656-5665.
45. Rosenthal DS, Simbulan-Rosenthal CM, Liu WF, Velena A, Anderson D, Benton B, Wang ZQ, Smith W, Ray R, Smulson ME. PARP determines the mode of cell death in skin fibroblasts, but not keratinocytes, exposed to sulfur mustard. J Invest Dermatol 2001;117:1566-1573.
46. Kan RK, Pleva CM, Hamilton TA, Anderson DR, Petrali JP. Sulfur mustard-induced apoptosis in hairless guinea pig skin. Toxicol Pathol 2003;31:185-190.
47. Schulze-Osthoff K, Ferrari D, Los M, Wesselborg S, Peter ME. Apoptosis signaling by death receptors. Eur J Biochem 1998;254:439-459.
48. Li Y, Hashimoto Y, Agadir A, Kagechika H, Zhang X. Identification of a novel class of retinoic acid receptor beta-selective retinoid antagonists and their inhibitory effects on AP-1 activity and retinoic acid-induced apoptosis in human breast cancer cells. J Biol Chem 1999;274:15360-15366.
49. Xu XC, Liu X, Tahara E, Lippman SM, Lotan R. Expression and up-regulation of retinoic acid receptor-beta is associated with retinoid sensitivity and colony formation in esophageal cancer cell lines. Cancer Res 1999;59:2477-2483.
50. Srivastava RK, Srivastave AR, Cho-Chung YS. Synergistic effects of 8-C1-cAMP and retinoic acids in the inhibition of growth and induction of apoptosis in ovarian cancer cells: Induction of retinoic acid receptor beta. Mol Cell Biochem 2000;204:1-9.
51. Sartorius U, Schmitz I, Krammer PH. Molecular mechanisms of death-receptor-mediated apoptosis. Chembiochem 2001;2:20-29.
52. Bodmer JL, Schneider P, Tschopp J. The molecular architecture of the TNF superfamily. Trends Biochem Sci 2002;27:19-26.
53. Srivastava RK, Srivastava AR, Cho-Chung YS, Longo DL. Synergistic effects of retinoic acid and 8-chloro-adenosine 3′,5′-cyclic monophosphate on the regulation of retinoic acid receptor beta and apoptosis: Involvement of mitochondria. Clin Cancer Res 1999;5:1892-1904.
54. Lee MO, Han SY, Jiang S, Park JH, Kim SJ. Differential effects of retinoic acid on growth and apoptosis in human colon cancer cell lines associated with the induction of retinoic acid receptor beta. Biochem Pharmacol 2000;59:485-496.
55. Okamoto K, Beach D. Cyclin G is a transcriptional target of the p53 tumor suppressor protein. EMBO J 1994;13:4816-4822.
56. Smith ML, Kontny HU, Bortnick R, Fornace AJ Jr. The p53-regulated cyclin G gene promotes cell growth: p53 downstream effectors cyclin G and Gadd45 exert different effects on cisplatin chemosensitivity. Exp Cell Res 1997;230:61-68.
57. Okamoto K, Prives C. A role of cyclin G in the process of apoptosis. Oncogene 1999;18:4606-4615.
58. Boley SE, Wong VA, French JE, Recio L. p53 heterozygosity alters the mRNA expression of p53 target genes in the bone marrow in response to inhaled benzene. Toxicol Sci 2002;66:209-215.
59. Chen X. Cyclin G: A regulator of the p53-Mdm2 network. Dev Cell 2002;2:518-519.
60. Di Giovanni S, Knoblach SM, Brandoli C, Aden SA, Hoffman EP, Faden AI. Gene profiling in spinal cord injury shows role of cell cycle in neuronal death. Ann Neurol 2003;53:454-468.
61. Ohtsuka T, Ryu H, Minamishima YA, Ryo A, Lee SW. Modulation of p53 and p73 levels by cyclin G: Implication of a negative feedback regulation. Oncogene 2003;22:1678-1687.
62. Smith KJ, Graham JS, Hamilton TA, Skelton HG, Petrali JP, Hurst CG. Immunohistochemical studies of basement membrane proteins and proliferation and apoptosis markers in sulfur mustard induced cutaneous lesions in weanling pigs. J Dermatol Sci 1997;15:173-182.
63. Meier HL, Millard CB. Alterations in human lymphocyte DNA caused by sulfur mustard can be mitigated by selective inhibitors of poly(ADP-ribose) polymerase. Biochim Biophys Acta 1998;1404:367-376.
64. Meier HL, Millard C, Moser J. Poly(ADP-ribose) polymerase inhibitors regulate the mechanism of sulfur mustard-initiated cell death in human lymphocytes. J Appl Toxicol 2000;20:S93-S100.
65. Sabourin CLK, Rogers JV, Stonerock MK, Niemuth NA, Kiser RC, Casbohm SL, Babin MC, Schlager JJ, Casillas RP. Alterations of gene expression in sulfur mustard-exposed skin topically-treated with vanilloids. J Toxicol Cutan Ocular Toxicol 2004;23:321-328.